ADMdx, in collaboration with Dr. Jeffrey Cummings, Dr. Jefferson Kinney, and other leading researchers has published work demonstrating relationships between blood biomarkers and brain imaging in patients with Alzheimer’s Disease. The publication, titled “Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in Alzheimer's disease patients” has been published in the July 9 2024 issue of the Journal of Alzheimers & Dementia:TRCI (doi: 10.1002/trc2.12490). In this work, ADMdx examined associations of blood biomarkers of amyloid, neurodegeneration, and neuroinflammation as compared to brain glucose metabolism measured through FDG PET, tau burden measured using flortaucipir tau PET, and brain volume quantified using ADMdx’s CorInsights MRI diagnostic report. Correlations were observed between several of the plasma and imaging biomarkers, and the work demonstrated the insight that can be gained to patient disease and status through combining plasma and imaging biomarkers.